Effects of Selected Oligosaccharides on Fecal Microflora and Lipid Constitution in Rats

다양한 종류의 올리고당이 흰쥐의 분변내 균총과 지질 성상에 미치는 영향

  • 최은혜 (이화여자대학교 식품영양학과)
  • Published : 1999.04.01

Abstract

Certain indigestible oligosaccharides may benefit gastrointestinal tract via fermentation and proliferation of desirable bacterial species. The purose of this study was to elucidate the effect of selected oligosaccharides, such as fructooligosaccharides(FOS), soybean oliosaccharides(SOE), and highly concentrated branched oligosaccharides(HiBOS), on fecal micorflora proliferation, lipid concentration, lipid peroxide formation and antioxidant enzymes acitivies in plasma and liver of the rats. Thirty two male Sprague-Dawley rats were randomly assigned to one of four treatments ; 1) control diet(AIN-93G diet); 2) control diet +5% FOS ; 3) control diet + 5% SOE ; 4) control diet + 5% HiBOS. The duration of the study was 4 weeks. Fecal bifidobacteria concentration were significantly higher (p<0.05) in the HiBOS group compared with the control after 4 weeks of dietary treatment. FOS and SOE groups also had higher fecal bifidobacteria levels than control, but statistical significance was not found. The concentration of plasma total lipid was decreased by oligosaccharide consumption, especially in HiBOS group(p<0.05). The concentration of plasma total triglyceride was significantly lower in all of the oligosaccharide containing groups compared with the control(p<0.05). The plasma total cholesterol concentration tended to be lower in the oligosaccharide consuming groups than control. The concentrations of hepatic total lipid, triglyceride and total cholesterol were not affected by consumption of oligosaccharides. Thiobarbituric acid reactive substance(TBARS) concentrations and antioxidant enzyme activities in plasma and liver were not affected much by experimental diets. There results suggest that dietary oligosaccharides may be beneficial for increasing intestinal bifidobacteria and lowering plasma lipid levels.

Keywords

References

  1. Bifidobacteria Microflora v.5 Effects of fructooligosaccharides on intestinal flora and human health Hidaka, H;Eida, T;Takizawa, T;Tokunaga, T;Tashiro, Y
  2. Bifidobacteria Microflora v.1 no.3 Recent trends in research on intestinal flora Mitsuoka, T
  3. Can Inst Food Sci Technol J v.23 Bifidobacteria and bifidogenic factors Modler HW;Mckeller RC;Yaguchi M
  4. J Ind Microbiol v.6 Bifidobacteria and their role in human health Mitsuoka T
  5. Pharmac Ther v.10 Clostridium perfringens toxins(Type A, B, C, D, E) McDonel JL
  6. Am J Clin Nutr v.32 Microbial metabolites of tryptophan in the intestinal tract with special reference to skatole Yokoyama MT;Carlson JR
  7. Bifidobacteria Microflora v.9 Effect of xylooligosaccharide on the growth of bifidobacteria Okazaki M;Fujikawa S;Matsumoto N
  8. Microbial ecology in health and disease v.3 Effects of soybean oligosaccharides on human faecal flora Hayakawa K;Mizutani J;Wada K;Masai T;Yoshihara I;Mitsuoka T
  9. Microbial ecology in health and disease v.5 Effects of soybean oligosaccharides on the human gut microflora in vitro culture Saito Y;Takano T;Rowland I
  10. Am J Clin Nutr v.57 Dietary fructooligosaccharides modify lipid metabolism in rats Delzenne N;Kok N;Fiordaliso M;Deboyser DM;Goethals FM;Roberfroid MB
  11. J Nutr v.124 Role of dietary propionic acid and bile acid excretion in the hypocholesterolemic effects of oligosaccharides in rats Levrat M;Favier M;Moundras C;Rmsy C;Demign C;Morand C
  12. Oligosaccharides-The leader of functional foods Heo KT
  13. Food Science and Industry v.27 no.4 Internal trends in research and development of oligosaccharides Seo JH
  14. Kor J Food Technol v.27 no.2 Physical and physiological properties of isomaltooligosaccharides and fructooligosaccharides Kim JR;Yook C;Kwon HK;Hong SY;Park CK;Park KH
  15. Kor J Appl Microbiol Biotechnol v.20 no.3 Growth effect of branched oligosaccharides on principal intestinal bacteria Park JH;Yoo JY;Shinn OH;Shin HK;Lee SJ;Park KH
  16. Kor J Food Technol v.28 no.4 Effects of the fructooligosaccharide intake on human fecal microflora and fecal properties Kang KH;Kim KM;Choi SG
  17. J Nutr v.123 AIN-93 purified diets for laboratory rodents : Final report of the American Institute Nutrition Ad Hoc Wrighting Committee on the reformulation of the AIN-79A rodent diet Reeves PG;Nielsen FH;Fahey GC
  18. Am J Clin Pathol v.53 A colorimetric method for determination of total serum lipids based on the sulfphosphovanillin reaction Frings CS;Dunn RT
  19. Can J Biochem Physiol v.37 A rapid method of total lipid extraction and purification Bligh EG;Dyer WJ
  20. Method in enzymology v.105 Assay for blood plasma or serum Yagi K
  21. J Nutr v.115 Effect of dietary polyunsaturated/saturated fatty acid ratio and dietary vitamin E on lipid peroxidation in the rat Buckingham KW
  22. CRC handbook of free radicals and antioxidants in biomedicine Convenient assays for superoxide dismutase Folcher L;Becker R;Brigelius R;Lengfelder E;Otting F;Miquel J(ed.);Quintanilha AT(ed.);Weber H(ed.)
  23. J Lab Clin Med v.35 The estimation of red cell superoxide dismutase activity Winterbourn CC;Hawkins RE;Brain M;Carrell RW
  24. Analytical Biochem v.174 A spectrophotometric method for determination of catalase activity in small tissue samples Johansson LH;Hankan Borg LA
  25. J Lab Clin Med v.70 Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase Paglia DE;Valentine WN
  26. J Nutr v.128 Plasma lipids and fatty acid synthase activity are regulated by short-chain fructo-oligosaccharides in sucrose-fed insulin-resistant rats Agheli N;Kabir M;Berni-Canani S;Petitjean E;Boussairi A;Luo J;Bornet F;Slama G;Rizkalla SW
  27. J Nutr v.125 Dietary fructooligosaccharide, xylooligosaccharide and gum arabic have variable effects on cecal and colonic microbiota and epithelial cell proliferation in mice Howard MD;Gordon DT;Garleb KA;Kerley MS
  28. Br J Nutr v.78 no.2 Compared effects of three oligosaccharides on metabolism of intestinal microflora in rats inoculated with a human faecal flora Djouzi Z;Andrieux C
  29. Food Science and Industry v.25 no.2 Development of new materials from carbohydrate Park KH
  30. Proceedings of the International Symposium on caloric evaluation carbohydrates Changes of soybean oligosaccharides in the digestive tract Ohmura K;Maruta K;Kato Y;Hayakawa K;Hosoya N(ed.)
  31. どつイズス v.5 Effects of soybean oligosaccharides intake on fecal microflora Wada K;Mizutani J;Watabe J;Suzuki H;Sirayanagi S
  32. Production of highly concentrated branched oligosaccharides using yeast fermentation Kim MJ
  33. Ann Nutr Metab v.35 Hypolipidemic effects of guar gum and its enzyme hydrolysate in rats fed highly saturate fat diets Ide T;Moriuchi H;Nihimoto K
  34. Lipids v.30 Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats Fiordaliso M;Kok N;Desager J;Goethals F;Deboyser D;Roberfroid M;Delzenne N
  35. Br J Nutr v.76 Involvement of lipogenesis in the lower VLDL secretion induced by oligofructose in rats Kok N;Roberfroid M;Robert A;Delzenne N
  36. J Appl Toxicol v.18 Oligofructose modulates lipid metabolism induced by a fat-rich diet in rats Kok NN;Taper HS;Delzenne NM
  37. Kor J Nutr v.31 Effects of the fructooligosaccharides on lipid metabolism in hypercholesterolemic rat Oh JS;Kim WK;Kim YH;Kim HY;Choi EH;Kim SH
  38. Eur Heart J v.12 Triglycerides, a major coronary risk factor in elderly men. a study of men born in 1913 Welin L;Eriksson H;Larsson B;Ohlson LO;Svardsudd K;Tibblin G;Wilhelmsen L
  39. Am J Clin Nutr v.52 Erythrocyte fatty acids, plasma lipids and cardiovascular disease in rural china Wenxun F;Parker R;Parpia B;Yinsheng Q;Casasno P;Crawford M;Leyton J;Tian J;Junshi C;Campbell TC
  40. The Lancet v.344 Free radicals, antioxidants, and human disease : Curiosity, cause, or consequence? Barry H
  41. J Nutr v.122 Regulation of antioxidant enzymes Harris ED
  42. Ann Rev Nutr v.5 Mechanism and consequences of lipid peroxidation in biological system Sevanian A;Hochstein P
  43. Free Radical Biol Med v.19 Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidemia Nacitarhan S;Ozben T;Tuncer N